Photodistributed telangiectasia following use of escitalopram

Photodistributed telangiectasia following use of escitalopram

Bibliographic Details
Main Authors:	Mario Vaccaro, Gioacchino Calapai, Fabrizio Guarneri, Carmen Mannucci, Maria Lentini, Serafinella P. Cannavò
Format:	Article
Language:	English
Published:	Elsevier 2016-07-01
Series:	Allergology International
Online Access:	http://www.sciencedirect.com/science/article/pii/S1323893016000058

Similar Items

A photodistributed eruption in an immunosuppressed patient
by: Alysha Colon, MD, et al.
Published: (2021-09-01)

Airborne contact dermatitis and asthma in a nail art operator
by: Mario Vaccaro, et al.
Published: (2014-02-01)

Photodistributed sarcoidosis: a case report and approach to management
by: Cristina Olteanu, et al.
Published: (2018-09-01)

Urticaria and hyposideremia: a case report
by: Annunziata Bartolotta, et al.
Published: (2017-06-01)

Unusual presentation of idiopathic sweet′s syndrome in a photodistributed pattern
by: Rajesh Verma, et al.
Published: (2014-01-01)

Early and Late Onset Side Effects of Photodynamic Therapy
by: Francesco Borgia, et al.
Published: (2018-01-01)

Photodistributed toxic epidermal necrolysis in association with lamotrigine and tanning bed exposure
by: Kristen Russomanno, MD, et al.
Published: (2021-08-01)

Relapsing Polychondritis: An Updated Review
by: Francesco Borgia, et al.
Published: (2018-08-01)

Commentary: Circulatory pattern of cytokines, adipokines and bone markers in postmenopausal women with low BMD
by: Carmen Mannucci, et al.
Published: (2019-11-01)

Kombinationstherapie mit Escitalopram und Quetiapin versus Monotherapie mit Escitalopram
by: Schmotz, Christian
Published: (2013)

Intense suicidal thoughts and self-harm following escitalopram treatment
by: Farooq Khan, et al.
Published: (2011-01-01)

Cannabinoids, Blood–Brain Barrier, and Brain Disposition
by: Fabrizio Calapai, et al.
Published: (2020-03-01)

Factitious Cushing’s syndrome, hypopituitarism, and self-provoked skin lesions: when the skin mirrors the soul
by: Salvatore Cannavò, et al.
Published: (2021-09-01)

Preclinical and Clinical Pharmacology of Hydrocodone for Chronic Pain: A Mini Review
by: Luigi Cardia, et al.
Published: (2018-10-01)

Oxidative Stress and Atopic Dermatitis
by: Lucrezia Bertino, et al.
Published: (2020-02-01)

Escitalopram Induced Drug Eruption
by: Bhatia M S
Published: (2004-01-01)

Severe hyponatremia associated with escitalopram
by: Gautam Rawal, et al.
Published: (2017-01-01)

Research and Development for Botanical Products in Medicinals and Food Supplements Market
by: Marco Miroddi, et al.
Published: (2013-01-01)

Experimental Study of the Analgesic Effect of the Antidepressant Escitalopram
by: Zlatanova Hristina I., et al.
Published: (2018-09-01)

Effect of escitalopram on the processing of emotional faces
by: W.C. Alves-Neto, et al.
Published: (2010-03-01)

Hypnic jerks possibly induced by escitalopram
by: Harshal Sathe, et al.
Published: (2015-03-01)

Auditory System Involvement in Psoriasis
by: Francesco Borgia, et al.
Published: (2018-04-01)

Which Patients Are Prescribed Escitalopram?: Predictors for Escitalopram Prescriptions and Functional Outcomes among Patients with Acute Ischemic Stroke
by: Jarim Kim, et al.
Published: (2018-05-01)

Unilateral galactorrhea associated with low-dose escitalopram
by: P Bangalore Ravi, et al.
Published: (2014-01-01)

Preclinical and Clinical Evidence Supporting Use of Cannabidiol in Psychiatry
by: Gioacchino Calapai, et al.
Published: (2019-01-01)

Telangiectasia hemorrágica hereditaria Hereditary hemorrhagic telangiectasia
by: Raymundo Rafael Fernández Díaz, et al.
Published: (2009-04-01)

Ataxia telangiectasia
by: Letícia Sauma, et al.
Published: (2015-07-01)

Depression in acromegaly treated with escitalopram and cognitive therapy
by: De Sousa Avinash
Published: (2009-01-01)

Reversible Hemifacial Spasm after Starting Escitalopram
by: Mazen Abdulrahaman Basheikh
Published: (2020-03-01)

Safety of escitalopram in pregnancy: a case series
by: Bellantuono C, et al.
Published: (2013-09-01)

The therapeutic potential of escitalopram in the treatment of panic disorder
by: Mark H Townsend, et al.
Published: (2007-01-01)

A rare adverse drug reaction to escitalopram
by: Monika Pathania, et al.
Published: (2018-01-01)

Clinical efficacy of Vortioxetine and escitalopram in the treatment of depression
by: Shao, S., et al.
Published: (2022)

Thyroid Autoimmunity and Lichen
by: Fabrizio Guarneri, et al.
Published: (2017-06-01)

Nutraceuticals against Oxidative Stress in Autoimmune Disorders
by: Carmen Mannucci, et al.
Published: (2021-02-01)

Citrus bergamia essential oil: from basic research to clinical application
by: Michele eNavarra, et al.
Published: (2015-03-01)

Ataxia-telangiectasia
by: Nelson Pires Ferreira
Published: (1966-09-01)

Ataxia-Telangiectasia
by: J Gordon Millichap
Published: (1990-01-01)

Use of escitalopram to prevent depression and cognitive impairments in the acute phase of stroke
by: Dina Rustemovna Khasanova, et al.
Published: (2013-11-01)

Cost-effectiveness evaluation of escitalopram in major depressive disorder in Italy
by: Mencacci C, et al.
Published: (2013-02-01)